Profund Advisors’s Inhibrx INBX Stock Holding History

Profund Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$473K	Buy	7,032 +3,761	+115%	+$279K	0.02%	567
2025 Q4	$258K	Buy	+3,271	New	+$223K	0.01%	987

Other funds holding INBX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Profund Advisors's INBX Position: Q1 2026 in Review

Profund Advisors increased its Inhibrx (INBX) stake by 115% in Q1 2026, buying an estimated $279K and bringing the position to 7,032 shares worth $473K. The position accounts for 0.02% of the portfolio, ranked #567.

Profund Advisors first reported a position in INBX in Q4 2025 and has held it in 2 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

Profund Advisors held 7,032 shares of Inhibrx worth $473K as of Q1 2026.
Profund Advisors bought 3,761 Inhibrx shares in Q1 2026, an estimated $279K.
Inhibrx made up 0.02% of Profund Advisors's portfolio in Q1 2026, its #567 holding.
Profund Advisors first reported a position in Inhibrx in Q4 2025 and has held it in 2 quarters since.
135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.